- Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
-
Kaya E, Bakir A, Kani HT, Demirtas CO, Keklikkiran C, Yilmaz Y
- KMID: 2504205
- Gut Liver.
- 2020 Jul;14(4):486-491.
- doi: 10.5009/gnl19173
Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
-
Yilmaz Y, Ayyildiz T, Akin H, Colak Y, Ozturk O, Senates E, Tuncer I, Dolar E
- KMID: 1774566
- Gut Liver.
- 2014 May;8(3):313-317.
BACKGROUND/AIMS: We sought to examine whether the presence of gallstone disease (GD) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) is associated with liver fibrosis and histological nonalcoholic steatohepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of increased aspartate aminotransferase to alanine aminotransferase (De Ritis) ratio in prognosis of testicular cancer
-
Gorgel SN, Akin Y, Koc EM, Kose O, Ozcan S, Yilmaz Y
- KMID: 2444271
- Investig Clin Urol.
- 2019 May;60(3):169-175.
- doi: 10.4111/icu.2019.60.3.169
PURPOSE: Imaging studies can show metastasis in testicular cancer (TCa); however, a test for risk of metastasis in TCa has not been described. The ratio of aspartate aminotransferase to alanine... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of hyperbaric oxygen and iloprost on intestinal ischemia-reperfusion induced acute lung injury
-
Yilmaz Y, Tumkaya L
- KMID: 2429752
- Ann Surg Treat Res.
- 2019 Jan;96(1):34-40.
- doi: 10.4174/astr.2019.96.1.34
PURPOSE: To research the effects of iloprost (IL) and hyperbaric oxygen (HBO) combination treatment on lung injury and on tumor necrosis factor alpha (TNF-α), myeloperoxidase (MPO), malondialdehyde (MDA), and soluble... -
- CITED
-
- Close
- SHARE
-
- Close
